日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product

针对纳米颗粒咪喹莫特制剂作为试验药物的质量源于设计 (QbD) 方法

Jonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, Anna-Maria Ciciliani, Mark Denny, Michael Klak, Berenice M Lang, Petra Staubach, Stephan Grabbe, Hansjörg Schild, Markus P Radsak, Hilde Spahn-Langguth, Peter Langguth

I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes

在人房颤肌细胞内毒素水平升高的情况下,伊伐布雷定的 I(f) 阻断效力得以保留。

Scheruebel, Susanne; Koyani, Chintan N; Hallström, Seth; Lang, Petra; Platzer, Dieter; Mächler, Heinrich; Lohner, Karl; Malle, Ernst; Zorn-Pauly, Klaus; Pelzmann, Brigitte

NADH supplementation decreases pinacidil-primed I K ATP in ventricular cardiomyocytes by increasing intracellular ATP.

NADH 补充剂通过增加细胞内 ATP 来降低心室心肌细胞中匹那地尔预处理的 IK ATP

Pelzmann Brigitte, Hallström Seth, Schaffer Peter, Lang Petra, Nadlinger Karl, Birkmayer George D, Vrecko Karoline, Reibnegger Gilbert, Koidl Bernd